Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gema Mateo

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 10, 2006
Conventional diagnostics in multiple myelomaJesús F San Miguel, Norma C Gutiérrez, Gema Mateo, et al.
Methods in Molecular Medicine|June 22, 2005
Immunophenotyping of plasma cells in multiple myelomaGema Mateo Manzanera, Jesús F San Miguel Izquierdo, Alberto Orfao de Matos
British Journal of Haematology|November 25, 2003
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agentsAtanasio Pandiella, Xonia Carvajal-Vergara, Soraya Tabera, et al.
International Journal of Cancer|December 21, 2004
Bortezomib is an efficient agent in plasma cell leukemiasAzucena Esparís-Ogando, Adrián Alegre, Beatriz Aguado, et al.
Cancer Research|June 3, 2006
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistancePatricia Maiso, Xonia Carvajal-Vergara, Enrique M Ocio, et al.
Clinical Lymphoma|March 30, 2005
Cell cycle analysis of Waldenstrom's macroglobulinemiaEnrique M Ocio, Gema Mateo, Belen Vidriales, et al.
British Journal of Haematology|July 9, 2002
Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effectAlejandro Martín, Ramón García-Sanz, José Hernández, et al.
Clinical Lymphoma|March 30, 2005
Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphomaEnrique M Ocio, Jesus M Hernandez, Gema Mateo, et al.
Cancer|February 14, 2006
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoireMartin Pérez-Andres, Julia Almeida, Marta Martin-Ayuso, et al.
Cytometry. Part B, Clinical Cytometry|February 16, 2010
Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disordersBruno Paiva, Julia Almeida, Martin Pérez-Andrés, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|June 10, 2006
Conventional diagnostics in multiple myelomaJesús F San Miguel, Norma C Gutiérrez, Gema Mateo, et al.
Methods in Molecular Medicine|June 22, 2005
Immunophenotyping of plasma cells in multiple myelomaGema Mateo Manzanera, Jesús F San Miguel Izquierdo, Alberto Orfao de Matos
British Journal of Haematology|November 25, 2003
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agentsAtanasio Pandiella, Xonia Carvajal-Vergara, Soraya Tabera, et al.
International Journal of Cancer|December 21, 2004
Bortezomib is an efficient agent in plasma cell leukemiasAzucena Esparís-Ogando, Adrián Alegre, Beatriz Aguado, et al.
Cancer Research|June 3, 2006
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistancePatricia Maiso, Xonia Carvajal-Vergara, Enrique M Ocio, et al.
Clinical Lymphoma|March 30, 2005
Cell cycle analysis of Waldenstrom's macroglobulinemiaEnrique M Ocio, Gema Mateo, Belen Vidriales, et al.
British Journal of Haematology|July 9, 2002
Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effectAlejandro Martín, Ramón García-Sanz, José Hernández, et al.
Clinical Lymphoma|March 30, 2005
Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphomaEnrique M Ocio, Jesus M Hernandez, Gema Mateo, et al.
Cancer|February 14, 2006
Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoireMartin Pérez-Andres, Julia Almeida, Marta Martin-Ayuso, et al.
Cytometry. Part B, Clinical Cytometry|February 16, 2010
Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disordersBruno Paiva, Julia Almeida, Martin Pérez-Andrés, et al.
Pageof 3